Form 4: Vaxcyte SVP Disposes Shares for Tax Obligations
Insider Transaction Report
Vaxcyte's SVP of Finance, Elvia Cowan, disposed of 482 shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- Elvia Cowan, SVP of Finance at Vaxcyte, Inc. (PCVX), reported a transaction on September 8, 2025.
- The transaction involved the disposition of 482 shares of Vaxcyte common stock.
- These shares were surrendered to the issuer to cover applicable tax withholding obligations realized upon the vesting of Restricted Stock Units (RSUs).
- The shares were valued at $32.41 per share for the purpose of this transaction.
- Following this transaction, Elvia Cowan directly beneficially owns 26,156 shares of Vaxcyte common stock.
Sentiment
Score: 5
Explanation: Neutral. This is a routine, non-discretionary transaction related to RSU vesting and tax obligations, which is a common occurrence for executives and does not reflect a change in the company's operational or financial performance.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Disposition of 482 common shares to Vaxcyte, Inc. to cover tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) for Elvia Cowan, SVP of Finance.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a routine, non-discretionary transaction for tax purposes, not a sale for personal gain or a reflection of company performance.
- Positive for the employee (Elvia Cowan) as it represents the realization of vested equity compensation.
Key Dates
| Date | Description |
|---|---|
| 09/08/2025 | Date of earliest transaction (shares disposed for tax withholding) |
| 09/10/2025 | Signature date of the reporting person's attorney-in-fact |
Keywords
Vaxcyte, PCVX, Elvia Cowan, Form 4, Insider Transaction, RSU, Stock Vesting, Tax Withholding, Biotechnology, Pharmaceutical
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.